Letters
GLP-1R agonists and weight loss
Utility of GLP-1R agonists in diabetes requires long term study
BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e1451 (Published 28 February 2012) Cite this as: BMJ 2012;344:e1451
- Jose Mario Franco de Oliveira, associate professor of medicine1
- 1Department of Medicine, Universidade Federal Fluminense, Rio de Janeiro, RJ 22230-001, Brazil
- jmariofranco{at}gmail.com
What is the clinical relevance to diabetes treatment of the meta-analysis of the effects of glucagon-like peptide-1 receptor (GLP-1R) agonists on weight loss, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.